About Index Trending news
Lists
Pricing
Amplyx Pharmaceuticals, Inc

Amplyx Pharmaceuticals, Inc

Amplyx Pharmaceuticals, Inc

Amplyx Pharmaceuticals is developing novel, broadspectrum antifungal agents for the treatment of lifethreatening invasive fungal infections due to candida, aspergillus and rare molds..

Elsewhere

Alexa global traffic share

01 Aug 2017
$67,000,000
Venture capital (Series C)

Antifungal biotech Amplyx Pharmaceuticals raises $67 million

sandiegouniontribune.com
+1
10 Feb 2016
$8,700,000
Venture capital (Series B)
3×5 Partners

Amplyx Pharmaceuticals Raises $8.7M Investment from 3×5 Partners

FinSMEs